These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 16967504

  • 1. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I.
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.
    Nosheny RL, Bachis A, Acquas E, Mocchetti I.
    Eur J Neurosci; 2004 Dec; 20(11):2857-64. PubMed ID: 15579139
    [Abstract] [Full Text] [Related]

  • 3. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 4. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 15; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 5. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A, Bauer M, Thöny B, Aebischer P.
    J Neurochem; 2005 Jun 15; 93(6):1482-6. PubMed ID: 15935064
    [Abstract] [Full Text] [Related]

  • 6. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
    Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM.
    Ann N Y Acad Sci; 2007 Dec 15; 1122():144-54. PubMed ID: 18077570
    [Abstract] [Full Text] [Related]

  • 7. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 15; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 8. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo.
    Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I.
    Eur J Neurosci; 2007 Apr 15; 25(8):2275-84. PubMed ID: 17445226
    [Abstract] [Full Text] [Related]

  • 9. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X, Hagg T.
    J Comp Neurol; 1997 Nov 24; 388(3):484-94. PubMed ID: 9368855
    [Abstract] [Full Text] [Related]

  • 10. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ, Bian GL, Bai Y, Cao R, Chen LW.
    Neurochem Int; 2008 Sep 24; 53(3-4):56-62. PubMed ID: 18639597
    [Abstract] [Full Text] [Related]

  • 11. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 24; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 12. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF, Zhang JL, Large DM, Wilson PE, Gash CR, Thomas TC, Haycock JW, Bing G, Stanford JA, Gash DM, Gerhardt GA.
    J Neurochem; 2004 Jul 24; 90(1):245-54. PubMed ID: 15198683
    [Abstract] [Full Text] [Related]

  • 13. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C, Georgievska B, Carlsson T, Lacar B, Kirik D.
    Neuroscience; 2006 Aug 11; 141(1):521-31. PubMed ID: 16697115
    [Abstract] [Full Text] [Related]

  • 14. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM, Pezzi S, Canals JM, Pallàs M, Alberch J.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):147-54. PubMed ID: 15790538
    [Abstract] [Full Text] [Related]

  • 15. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K, Jones SA, Hyman C, Zimmer J.
    Exp Neurol; 1996 Dec 24; 142(2):340-50. PubMed ID: 8934565
    [Abstract] [Full Text] [Related]

  • 16. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ, Batchelor PE, Howells DW.
    Exp Neurol; 2005 Mar 24; 192(1):226-34. PubMed ID: 15698637
    [Abstract] [Full Text] [Related]

  • 17. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M, Hoffer BJ, Olson L.
    J Neural Transplant Plast; 1997 Mar 24; 6(2):83-96. PubMed ID: 9306240
    [Abstract] [Full Text] [Related]

  • 18. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
    Mufson EJ, Kroin JS, Sobreviela T, Burke MA, Kordower JH, Penn RD, Miller JA.
    Exp Neurol; 1994 Sep 24; 129(1):15-26. PubMed ID: 7523178
    [Abstract] [Full Text] [Related]

  • 19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 20. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.
    J Neurosci Res; 2009 Aug 01; 87(10):2308-18. PubMed ID: 19326433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.